The efficacy and tolerability of a fixed combination of acetylsalicylic acid, paracetamol, and caffeine in patients with severe headache: A post-hoc subgroup analysis from a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study

Cephalalgia

Volumn 31, Issue 14, 2011, Pages 1466-1476

  Diener, H C ^a   Peil, H ^b   Aicher, B ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Acetylsalicylic acid; caffeine; combination analgesics; headache; migraine; paracetamol (acetaminophem); ROC analysis; severe headache pain

Indexed keywords

ANALGESIC AGENT; APC; NON PRESCRIPTION DRUG; PLACEBO;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ANALGESIA; ARTICLE; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; INCIDENCE; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA; POST HOC ANALYSIS; TABLET; TENSION HEADACHE; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE;

ACETAMINOPHEN; ADOLESCENT; ADULT; AGED; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CAFFEINE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PHOSPHODIESTERASE INHIBITORS; PLACEBOS; ROC CURVE; SEVERITY OF ILLNESS INDEX; TENSION-TYPE HEADACHE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80054682783     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102411419682     Document Type: Article

References (25)

1. The International Classification of Headache Disorders, 2nd edition (ICHD-2). Cephalalgia. 2004 ; 24 (Suppl. 1). 1-160
2. Stovner LJ, Andree C. Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain. 2010 ; 11 (4). 289-299
3. Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache. 2001 ; 41 (7). 638-645 (Pubitemid 32777746)
4. Rasmussen BK, Jensen R, Olesen J. Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Community Health. 1992 ; 46 (4). 443-446
5. Radtke A, Neuhauser H. Prevalence and burden of headache and migraine in Germany. Headache. 2009 ; 49 (1). 79-89
6. Haag G, Diener HC, May A, Meyer C, Morck H, Straube A, et al. Self-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migräne und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft für Neurologie (DGN), the sterreichische Kopfschmerzgesellschaft (KSG) and the Schweizerische Kopfwehgesellschaft (SKG). J Headache Pain. 2010 ; 12 (2). 201-217
7. Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B. The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia. 2005 ; 25 (10). 776-787 (Pubitemid 41368672)
8. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1998 ; 8 (Suppl 7). 1-96
9. Guideline for the clinical evaluation of analgesic drugs. Rockville: Centre for Drug Evaluation and Research ; 1992 :
10. Guidelines for controlled trials of drugs in migraine (first edition). Cephalalgia. 1991 ; 11 (1). 1-12
11. Guidelines for trials of drug treatments in tension-type headache (first edition). Cephalalgia. 1995 ; 15 (3). 165-179
12. Huskisson EC. Measurement of pain. Lancet. 1974 ; 2 (7889). 1127-1131
13. Pepe MS The statistical evaluation of medical tests for classification and prediction. New York, NY: Oxford University Press ; 2003 :
14. Laska EM, Sunshine A, Mueller F, Elvers WB, Siegel C, Rubin A. Caffeine as an analgesic adjuvant. JAMA. 1984 ; 251 (13). 1711-1718 (Pubitemid 14174176)
15. Lipton RB, Goldstein J, Baggish JS, Yataco AR, Sorrentino JV, Quiring JN. Aspirin is efficacious for the treatment of acute migraine. Headache. 2005 ; 45 (4). 283-292 (Pubitemid 40530192)
16. Lipton RB, Stewart W, Ryan R, Saper J, Silberstein S, Sheftell F. Efficacy and safety of the nonprescription combination of acetaminophen, aspirin, and caffeine in alleviating headache pain of an acute migraine attack: three double-blind, randomized, placebocontrolled trials. Arch Neurol. 1998 ; 55 (2). 210-217 (Pubitemid 128719369)
17. Goldstein J, Hoffman HJ, Armellino JJ, Battikha JP, Hamelsky SW, Couch J, et al. Treatment of severe, disabling migraine attacks in an over-the-counter population of migraine sufferers: results from three randomized, placebo-controlled studies of the combination of acetaminophen, aspirin, and caffeine. Cephalalgia. 1999 ; 19 (7). 684-691 (Pubitemid 29465920)
18. Kellstein DE, Lipton RB, Geetha R, Koronkiewicz K, Evans FT, Stewart WF, et al. Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebocontrolled, dose-ranging study. Cephalalgia. 2000 ; 20 (4). 233-243 (Pubitemid 32269494)
19. Prior MJ, Codispoti JR. A randomized, placebo-controlled trial of acetaminophen for treatment of migraine headache. Headache. 2010 ; 50 (5). 819-833
20. Dahlöf C, Jones M, Davis K, Loftus J, Salonen R. A comparison of preference for and efficacy of tablet formulations of sumatriptan (50 mg and 100 mg), naratriptan (2.5 mg), rizatriptan (10 mg), and zolmitriptan (2.5 mg) in the acute treatment of migraine. J Headache Pain. 2004 ; 5 (2). 115-122 (Pubitemid 39199675)
21. Goldstein J, Ryan R, Jiang K, Getson A, Norman B, Block GA, et al. Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Headache. 1998 ; 38 (10). 737-747 (Pubitemid 29031070)
22. Kolodny A, Polis A, Battisti WP, Johnson-Pratt L, Skobieranda F. Comparison of rizatriptan 5 mg and 10 mg tablets and sumatriptan 25 mg and 50 mg tablets. Cephalalgia. 2004 ; 24 (7). 540-546 (Pubitemid 39272954)
23. Láinez MJA, Evers S, Kinge E, Allais G, Allen C, Rao NA, et al. Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine. Cephalalgia. 2006 ; 26 (3). 246-256
24. Pascual J, Garcia-Monc C, Roig C, Izquierdo AY, Lopez-Gil A. Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference. Headache. 2005 ; 45 (9). 1140-1150 (Pubitemid 350004903)
25. Moore N, van Ganse E, Le Parc J-M, Wall R, Schneid H, Farhan M, et al. The PAIN study: parcetamol, aspirin, ibuprofen new tolerability study a large-scale, randomized clinical trial comparing the tolerability of aspirin, ibuprofen and paracetamol for short-term analgesia. Clin Drug Invest. 1999 ; 18 (2). 89-98 (Pubitemid 29391386)